Delivery Order SPE2DE24D0013-SPE2D625F2KUC
- Not listed
- The Medical Supply Chain, a defense-aligned federal agency, awarded a $7,700 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPRSARS-COV2-10 and issued on June 20, 2025, carries an ultimate completion date of June 27, 2025, with performance occurring in Sunnyvale, CA. The award includes no set-aside designation and represents a relatively modest procurement within...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- The Defense or Civilian agency within Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 22, 2025, with an ultimate completion date of July 29, 2025. This contract, identified as XPRSARS-COV2-10, involves delivery of molecular diagnostic solutions to the Sunnyvale, California location. The award carries no set-aside designation and represents a delivery order against one of Cepheid's existing Indefinite Delivery Vehicle contracts...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,117.50 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 11, 2025, for SARS-COV-2+ testing supplies. The contract, with an ultimate completion date of September 25, 2025, will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. This delivery order was issued without a set-aside designation, reflecting open and competitive procurement practices. The award represents...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The Defense Department's Medical Supply Chain awarded a $57.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 8, 2025, for molecular diagnostic solutions with an ultimate completion date of September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, will be performed in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic systems and associated test kits. This award carries no set-aside designation and represents a continuation of...
- The Defense Department's Medical Supply Chain has awarded a $24,088.95 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 21, 2025, represents procurement under Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. The delivery order designation...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,925 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPRSARS-COV2-10, was executed on July 22, 2025, with a completion date of July 29, 2025, and carries no set-aside designation. This delivery order represents a continuation of the federal government's ongoing procurement of Cepheid's diagnostic testing capabilities, likely...
- The U.S. Defense Department's Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, with an ultimate completion date of August 12, 2025. This delivery order, designated XPRSARS-COV2-10, carries no set-aside designation and represents a procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, including COVID-19,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2KUCDelivery Order
The U.S. Defense Department's Medical Supply Chain agency awarded a $7,700 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based molecular diagnostics manufacturer, on September 3, 2025, with an ultimate completion date of September 10, 2025. This delivery order, designated as XPRSARS-COV2-10, carries no set-aside designation and represents procurement of diagnostic solutions from Cepheid's established portfolio of molecular testing systems. The contract is issued from the Medical Supply Chain, a defense-affiliated agency, and will be performed at Cepheid's Sunnyvale headquarters. Cepheid is a recognized provider of molecular diagnostic solutions to federal healthcare systems, particularly the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company specializes in GeneXpert diagnostic systems and associated reagents for detecting infectious diseases including COVID-19, influenza, RSV, and other respiratory and clinical pathogens. This delivery order aligns with Cepheid's existing federal contracting relationships, including two significant Indefinite Delivery Vehicles with the VA's Veterans Integrated Service Networks valued at approximately $35.3 million combined, which enable ongoing procurement of diagnostic testing equipment and reagents through 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 9/3/25 |